Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Psychiatry
•
General Psychiatry
•
Neuromodulation
•
Ketamine
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
Related Questions
How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?
Do you warn patients about suicidal ideation when starting anti-seizure medications?
How do you approach antidepressant choices for patients with generalized anxiety disorder when the patient reports excessive sedation on low doses of SSRIs?
What antidepressants are recommended for management of depression or anxiety in patients with spinal cord injuries?
How do you approach psychotropic (demonstrated SSRIs and antipsychotics) induced urinary retention when a patient is otherwise having good response to treatment?
What do you do when a patient experiences multiple rounds of antidepressant-related tachyphylaxis?
How do you counsel patients regarding using stimulants for attention-deficit/hyperactivity disorder during pregnancy?
Do you routinely prescribe an anticholinergic agent for EPS prophylaxis when starting or continuing antipsychotics or do you prefer to use it only as needed (prn) if/when symptoms develop?
Given some of the theoretic relationship between glutamate and OCD do you every consider use of NMDA (or AMPA) antagonists for treatment refractory OCD?
What considerations do you take in starting stimulant medications for the management of adult ADHD?
